Sort
85,873 grants matching “alzheimers”
Advanced MR Imaging of Olfactory Impairment in Prodromal Alzheimer's Disease
$797,494Jun Hua · Hugo W. Moser Res Inst Kennedy Krieger · R01 · FY2021 · AG
Randomized Trial of Endotracheal Tubes to Prevent Ventilator-Associated Pneumonia - Prevent 2 Study
$797,451Miriam Treggiari · Yale University · R33 · FY2020 · HL
The Engaging Communities of Hispanics for Aging Research (ECHAR) Network
$797,413Luis D Medina · University Of Houston · R24 · FY2021 · AG
Identifying distinct tau polymorphs in Alzheimerâs disease and development of early diagnostics for aggregation of tau polymorphs
$797,318David Eisenberg · University Of California Los Angeles · R56 · FY2018 · AG
Enhancing Social Engagement through Online Gameplay for Older Adults with and without Mild Cognitive Impairment
$797,288Dillon Myers · Potluck, Llc · R44 · FY2025 · AG
Proteomics of Hypertension and Alzheimer's Disease in African Americans
$797,247Rena A. S. Robinson · Vanderbilt University · R01 · FY2023 · AG
Proteomics of Hypertension and Alzheimer's Disease in African Americans
$797,247Rena A. S. Robinson · Vanderbilt University · R01 · FY2022 · AG
Clinical Core
$797,102Hillel Grossman · Icahn School Of Medicine At Mount Sinai · P30 · FY2024 · AG
Amyloid-Beta Oligomer Selective Immunotherapy for Prodromal or Mild Alzheimer Disease
$797,087Eric Siemers · Acumen Pharmaceuticals, Inc. · U01 · FY2020 · AG
Religious Orders Study Core
$797,070David A Bennett · Rush University Medical Center · P30 · FY2015 · AG
Enhanced Quality in Primary Care for Elders with Diabetes and Dementia (EQUIPED-ADRD)
$797,045Joshua Chodosh · New York University School Of Medicine · R33 · FY2021 · AG
Targeting Biology of Aging Mechanisms Underlying Alzheimer's Disease Risk with Metformin
$797,023Sara Elyse Espinoza · Cedars-Sinai Medical Center · R01 · FY2025 · AG
A Physical Activity Intervention to Promote Cognitive Health, Cardiovascular Health and Sleep in Older Latinos
$797,015Gloria Adriana Perez · University Of Pennsylvania · R01 · FY2022 · AG
Development of class-IIa HDAC targeting PET probes for molecular imaging of disorders of the CNS
$796,986Nashaat Turkman · State University New York Stony Brook · R01 · FY2020 · AG
Development of class-IIa HDAC targeting PET probes for molecular imaging of disorders of the CNS
$796,986Nashaat Turkman · State University New York Stony Brook · R01 · FY2021 · AG
Development of class-IIa HDAC targeting PET probes for molecular imaging of disorders of the CNS
$796,986Nashaat Turkman · State University New York Stony Brook · R01 · FY2022 · AG
Midwest Roybal Center for Health Promotion and Translation
$796,979Susan L Hughes · University Of Illinois At Chicago · P30 · FY2019 · AG
Regulation of tau expression in Alzheimer disease and aging
$796,800John Fonda Crary · Icahn School Of Medicine At Mount Sinai · R01 · FY2018 · AG
Human Specific Brain DNA Methylation and Neuropsychiatric Diseases
$796,750Soojin Yi · Georgia Institute Of Technology · R01 · FY2015 · MH
Understanding the molecular mechanisms of Depression and Psychological Well-being in Alzheimer's disease
$796,700Thomas Spurgeon Wingo · Emory University · R01 · FY2017 · AG
Mechanisms of Adherence to Light Intensity Physical Activity to Prevent Alzheimer's Disease and Related Dementias
$796,682Jonathan G. Hakun · Pennsylvania State Univ Hershey Med Ctr · R33 · FY2024 · AG
Development and validation of novel models for cerebral small vessel disease and vascular cognitive impairment
$796,610Douglas Gould · University Of California, San Francisco · R33 · FY2021 · NS
Genetic Contribution to Brain Arterial Dilatation and its Role in Cognition and dementia
$796,592Jose Gutierrez · Columbia University Health Sciences · R01 · FY2019 · AG
Alzheimer's MultiOme Data Repurposing: Artificial Intelligence, Network Medicine, and Therapeutics Discovery
$796,538Feixiong Cheng · Cleveland Clinic Lerner Com-Cwru · U01 · FY2021 · AG
Alzheimer's MultiOme Data Repurposing: Artificial Intelligence, Network Medicine, and Therapeutics Discovery
$796,538Feixiong Cheng · Cleveland Clinic Lerner Com-Cwru · U01 · FY2023 · AG